Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:50 PM
Ignite Modification Date:
2025-12-24 @ 7:50 PM
NCT ID:
NCT03113604
Eligibility Criteria:
Inclusion Criteria:
* Patients over 18 years of age,
* Diagnosis of hepatocellular carcinoma (histological or non-invasive criteria of Barcelona),
Group 1: Tumor and peri-tumor tissue samples from patients with untreated CHCs sorafenib
\- Patients who received treatment other than sorafenib (chemo-embolization, radiofrequency, resection, ...),
Group 2: Tumor and peri-tumor tissue samples from patients with non-sorafenib CHC
* Patients treated with sorafenib,
* Patients not responding to treatment with sorafenib
Group 3: Tumor and peri-tumor tissue samples from patients with CHCs responding to sorafenib
* Patients treated with sorafenib,
* Patients responding to treatment with sorafenib
Exclusion Criteria:
* Age \<18 years,
* Patients who do not have liver biopsy specimens (PBH) available at the tumor bank,
* Patients who have refused to use their samples for biomedical research,
* Pregnancy and breast feeding
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT03113604
Study Brief:
Protocol Section:
NCT03113604